Skip to main content
Equibles

NewEdge Advisors, LLC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1633516 NEW ORLEANS, LA
Back to BTAI Full portfolio

Position in BTAI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,876
+$93 QoQ
Shares Held
1,331
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 47 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. BTAI ranks #23 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 36,078 $2,592,565
2 NBIX
Neurocrine Biosciences Inc
 12,619 $2,126,806
3 UTHR
UNITED THERAPEUTICS Corp
 3,861 $2,092,005
4 TEVA
Teva Pharmaceutical Industries Ltd
 37,994 $1,287,236
5 HLN
Haleon plc
 133,508 $1,245,629
6 HIMS
Hims & Hers Health, Inc.
 21,721 $753,067
7 VTRS
Viatris Inc
 39,976 $634,818
8 COLL
Collegium Pharmaceutical, Inc
 16,739 $605,951

All Filings in BTAI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,876 1,331
2026-03-31 $1,783 1,331
2025-12-31 $2,129 1,331
2025-09-30 $3,407 1,331
2025-06-30 $56 31
2025-03-31 $62 31
2024-12-31 $187 500
2024-09-30 $305 500
2024-06-30 $640 500
2024-03-31 $1,410 500
2023-12-31 $1,475 500
2023-09-30 $1,265 500
2023-06-30 $13,320 2,000
2023-03-31 $18,660 1,000
2022-12-31 $17,184 800